Google's Gemini AI assistant has reached 1 billion monthly active users, making it the company's fastest-growing product to date and its 14th offering to achieve this milestone.
Sundar Pichai announced the achievement on social media, highlighting Gemini's rapid adoption since launch. The AI assistant reached the 1B-user threshold faster than any previous Google product, underscoring the accelerating demand for AI-powered tools.
Gemini is now used by over 1 billion people monthly for tasks ranging from creative ideation to productivity workflows. The milestone places it among Google's most successful products, joining a list that includes Gmail, Chrome, Android, YouTube, and Search.
Pickai credited Josh Woodward and the Gemini team for the rapid expansion, while thanking users who have adopted the platform. The announcement signals Google's growing confidence in its AI capabilities as it competes with other large language models in a crowded generative AI market.
The speed of Gemini's growth reflects broader market trends. Generative AI tools have seen unprecedented adoption rates compared to traditional software products. Previous Google products took significantly longer to reach 1 billion users, with some requiring years of development and distribution before achieving this scale.
Gemini launched as Google's flagship AI assistant, designed to help users across multiple use cases. The product integrates with various Google services and is available across web, mobile, and other platforms, contributing to its widespread reach.
With 14 products now exceeding 1 billion users, Google maintains one of the largest portfolios of mega-scale services. The addition of Gemini demonstrates the company's ability to establish new products at massive scale, particularly in emerging categories like generative AI where competition remains intense.
Bluesky's mobile app is experiencing a sustained drop in active users over a year after its post-election growth spike. The platform is redirecting focus beyond its core application.
Abbott and Google Health have partnered to develop artificial intelligence tools for glucose monitoring. The collaboration aims to improve diabetes management through advanced sensor technology and machine learning.
Rivian CEO RJ Scaringe will speak at TechCrunch Disrupt 2026 to discuss the company's multi-pronged approach to electric vehicles, robotics, and autonomous technology. Scaringe plans to share lessons from his journey leading the EV manufacturer.
President Trump signed an executive order reducing vaccine programs while promoting vaccines that do not exist. The order repeats false claims linking shots to autism and calls the MMR vaccine "quite lethal."